Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis

被引:0
|
作者
Talal Asif
Aviral Vij
Bartlomiej Radzik
Hudson Stern
Patricia Simples
Quraish Ghadiali
Saurabh Malhotra
机构
[1] University of Missouri,Division of Cardiology, Truman Medical Center
[2] Cook County Health,Division of Cardiology
[3] Rush Medical College,Division of Cardiology
[4] Cook County Health,Division of Pathology
[5] Cook County Health,Division of Ophthalmology
来源
关键词
Hereditary transthyretin cardiac amyloidosis; Pyrophosphate scintigraphy; Cardiac magnetic resonance;
D O I
暂无
中图分类号
学科分类号
摘要
We present a case of a patient with worsening visual acuity and dense vitreal debris who was found to have vitreal transthyretin amyloid (ATTR) infiltration. Cardiac workup, performed to identify systemic amyloidosis, demonstrated focal myocardial amyloid infiltration on pyrophosphate (PYP) scintigraphy and cardiac magnetic resonance (CMR), resulting in a diagnosis of subclinical ATTR cardiac amyloidosis (ATTR-CA). Patient was identified as a carrier of p.S70R mutation which results in an aggressive ATTR phenotype. Patient is tolerating transthyretin silencer therapy well. Through this case, we discuss the role of a multimodality imaging approach for the diagnosis of subclinical ATTR-CA.
引用
收藏
页码:792 / 799
页数:7
相关论文
共 50 条
  • [41] Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
    Yamamoto, Hiroyuki
    Yokochi, Tomoki
    ESC HEART FAILURE, 2019, 6 (06): : 1128 - 1139
  • [42] Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis
    Alexander, Kevin M.
    Witteles, Ronald M.
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (06) : 1322 - 1324
  • [43] Amyloid transthyretin cardiac amyloidosis: diagnosis and management
    Di Giovanni, Bennett
    Gustafson, Dakota
    Delgado, Diego Hernan
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (09) : 673 - 681
  • [44] Hydroxymethylene diphosphonate for imaging transthyretin cardiac amyloidosis
    Joseph C. Lee
    Ramin Alipour
    Journal of Nuclear Cardiology, 2020, 27 : 1040 - 1040
  • [45] Hydroxymethylene diphosphonate for imaging transthyretin cardiac amyloidosis
    Lee, Joseph C.
    Alipour, Ramin
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (03) : 1040 - 1040
  • [46] The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
    Chaaban, Nourhan
    Kshatriya, Shilpa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [47] Early Identification of Transthyretin-Related Hereditary Cardiac Amyloidosis
    Arbustini, Eloisa
    Merlini, Giampaolo
    JACC-CARDIOVASCULAR IMAGING, 2014, 7 (05) : 511 - 514
  • [48] Hereditary transthyretin-related amyloidosis with exclusive cardiac phenotype
    Ciliberti, P.
    Quarta, C. C.
    Riva, L.
    Longhi, S.
    Galati, G.
    Villani, C.
    Salvi, F.
    Lorenzini, M.
    Branzi, A.
    Rapezzi, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 539 - 539
  • [49] Cardiac amyloidosis: A new challenge of multimodality imaging
    Nappi, Carmela
    Assante, Roberta
    Zampella, Emilia
    Cuocolo, Alberto
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (01) : 106 - 108
  • [50] Illustrative review of cardiac amyloidosis by multimodality imaging
    Hidekazu Tanaka
    Heart Failure Reviews, 2023, 28 : 113 - 122